Karo Pharma gains full control of Teva OTC portfolio
Premium
8 February 2021
Sweden’s Karo Pharma is acquiring a portfolio of OTC brands – including the Flux fluoride rinse and Decubal skincare products – from Israel’s Teva for EUR84 million (USD102 million).
